CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
Consistency of treatment effect across the range of baseline HbA1c in patients with type 2 diabetes mellitus (T2DM) treated with once-weekly dulaglutide or comparators in AWARD-1, -5 and -6
DOI 10.1055/s-0036-1580999
Bibliografische Angaben
Nachweis in CareLit
Autor:innenR Gentilella, G Sesti, R Buzzetti, LA Vázquez, C Nicolay
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe04/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Objective: To characterise the relative effects of once-weekly dulaglutide (DU) and active comparators on change in HbA1c across the continuous range of baseline HbA1c values. Methods: This exploratory post-hoc analysis included adult patients with T2DM randomised to DU1.5 mg, DU0.75 mg or exenatide 10mcg twice daily (AWARD-1; N = 835), DU1.5 mg, DU0.75 mg or sitagliptin 100 mg once daily (AWARD-5; N = 921), or DU1.…
Zitieren
Zitierempfehlung
R Gentilella, G Sesti, R Buzzetti, LA Vázquez, C Nicolay (2016) Consistency of treatment effect across the range of baseline HbA1c in patients with type 2 diabetes mellitus (T2DM) treated with once-weekly dulaglutide or comparators in AWARD-1, -5 and -6. Diabetologie und Stoffwechsel (04). https://doi.org/10.1055/s-0036-1580999
Mit CareLit weiterarbeiten